Interactions between hematopoietic growth factors in normal and leukemic stem cell differentiation.
Moore
M A
MA
James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
D000818:Animals; D001685:Biological Factors / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D016207:Cytokines; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D007942:Leukemia, Experimental; D015479:Leukemia, Myelomonocytic, Acute; D015473:Leukemia, Promyelocytic, Acute; D051379:Mice; D011994:Recombinant Proteins / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D001685:Biological Factors; D016207:Cytokines; D006133:Growth Substances; D007375:Interleukin-1; D011994:Recombinant Proteins; D014212:Tretinoin